These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 18753360)

  • 21. The role of heat shock protein 27 expression in hepatocellular carcinoma in Japan: special reference to the difference between hepatitis B and C.
    Harimoto N; Shimada M; Aishima S; Kitagawa D; Itoh S; Tsujita E; Maehara S; Taketomi A; Tanaka S; Shirabe K; Maehara Y
    Liver Int; 2004 Aug; 24(4):316-21. PubMed ID: 15287854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
    Ollivier I; Dauvois B; Guittet L; Boutreux S; Dupont B; Launoy G; Dao T
    Gastroenterol Clin Biol; 2010; 34(4-5):288-96. PubMed ID: 20189339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
    Xu HX; Lu MD; Xie XY; Yin XY; Kuang M; Chen JW; Xu ZF; Liu GJ
    Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
    Farinati F; Rinaldi M; Gianni S; Naccarato R
    Cancer; 2000 Dec; 89(11):2266-73. PubMed ID: 11147597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
    Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
    J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.
    Chen CH; Huang GT; Yang PM; Chen PJ; Lai MY; Chen DS; Wang JD; Sheu JC
    Eur J Cancer; 2006 Oct; 42(15):2524-9. PubMed ID: 16920352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections.
    Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Miyakawa Y; Kumada H
    J Med Virol; 2006 Apr; 78(4):459-65. PubMed ID: 16482557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
    Nguyen VT; Amin J; Law MG; Dore GJ
    J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
    Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
    Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
    J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for hepatocellular carcinoma in Southern Iran.
    Hajiani E; Masjedizadeh R; Hashemi J; Azmi M; Rajabi T
    Saudi Med J; 2005 Jun; 26(6):974-7. PubMed ID: 15983686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.